Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 11;19(1):66.
doi: 10.1186/s13722-024-00498-y.

Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial

Sebastian T Tong  1 , Kris Pui Kwan Ma  2 , Ajla Pleho  2 , Brennan Keiser  2 , Chialing Hsu  2 , Dawn M Ehde  3 , Mary C Curran  3 , Judith I Tsui  4 , Patrick J Raue  5 , Kari A Stephens  2
Affiliations

Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial

Sebastian T Tong et al. Addict Sci Clin Pract. .

Abstract

Background: Patients with chronic pain on opioids frequently experience loneliness, which is associated with poorer health outcomes and higher risk for opioid misuse and opioid use disorder. Given that almost half of opioids are prescribed in primary care, a critical need exists for the development and testing of interventions to reduce loneliness in primary care patients at risk for opioid misuse. Cognitive behavioral therapy and social prescribing have been shown to be efficacious in reducing loneliness and improving outcomes in other populations but have not been tested in patients at risk for substance use disorder. The overall objective of our study is to reduce opioid misuse and opioid use disorder by addressing loneliness in patients on long-term opioid therapy in real-world primary care settings.

Methods: We will conduct a 3-arm pragmatic, randomized controlled trial to compare the effectiveness of two group-based, telehealth-delivered interventions with treatment as usual: (1) cognitive behavioral therapy to address maladaptive thought patterns and behaviors around social connection and (2) a social prescribing intervention to connect participants with social opportunities and develop supportive social networks. Our primary outcome is loneliness as measured by the UCLA Loneliness Scale and our dependent secondary outcome is opioid misuse as measured by the Common Opioid Misuse Measure. We will recruit 102 patients on long-term opioid therapy who screen positive for loneliness from 2 health care systems in Washington State. Implementation outcomes will be assessed using the RE-AIM framework.

Discussion: Our study is innovative because we are targeting loneliness, an under-addressed but critical social risk factor that may prevent opioid misuse and use disorder in the setting where most patients are receiving their opioid prescriptions for chronic pain. If successful, the project will have a positive impact in reducing loneliness, reducing opioid misuse, improving function and preventing substance use disorder.

Trial registration: NCT06285032, issue date: February 28, 2024, original.

Keywords: Loneliness; Opioid analgesics; Opioid misuse; Opioid-related disorders; Psychosocial interventions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schedule of enrollment, interventions, and assessments
Fig. 2
Fig. 2
Study framework for loneliness and opioid misuse
See this image and copyright information in PMC

References

    1. Ingram I, Kelly PJ, Deane FP, Baker AL, Goh MC, Raftery DK, Dingle GA. Loneliness among people with substance use problems: a narrative systematic review. Drug Alcohol Rev. 2020;39(5):447–83. 10.1111/dar.13064 - DOI - PubMed
    1. National Institute on Drug Abuse. Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery 2022 [cited 2022 13 Jul]. https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-010.html
    1. Pai N, Vella S-L. COVID-19 and loneliness: a rapid systematic review. Australian New Z J Psychiatry. 2021;55(12):1144–56. 10.1177/00048674211031489 - DOI - PubMed
    1. Killgore WD, Cloonan SA, Taylor EC, Dailey NS. Loneliness: a signature mental health concern in the era of COVID-19. Psychiatry Res. 2020;290:113117. 10.1016/j.psychres.2020.113117 - DOI - PMC - PubMed
    1. Loades ME, Chatburn E, Higson-Sweeney N, Reynolds S, Shafran R, Brigden A, Linney C, McManus MN, Borwick C, Crawley E. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59(11):1218–39. e3. 10.1016/j.jaac.2020.05.009 - DOI - PMC - PubMed

Publication types

Substances

Associated data

LinkOut - more resources